Biodesix Inc share price logo

Biodesix Inc

NASDAQ: BDSX

Small Cap

$9.98

-0.14

(-1.41%)

as on

Biodesix Inc Stock Performance

as on April 29, 2026 at 6:54 am IST

  • Day's High

    $9.98
    $10.37

    3.91%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.44
    $20.21
    downward going graph

    65.57%

    Downside

    102.51%

    Upside

    downward going graph

Biodesix Inc share price movements today

Previous Close
$10.12
Open
$10.18
Volume
98.8K
Day's Low - High
$9.98 - $10.37
52 Week Low - High
$3.44 - $20.21

Biodesix Inc Historical Returns

1 Month Return
-28.75 %
3 Month Return
-1.98 %
1 Year Return
-11.6 %
3 Year Return
-70.74 %
5 Year Return
-97.03 %

Biodesix Inc Stock Fundamentals & Key Indicators

Check Biodesix Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$107.5M

EPS (TTM)

-3.08

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-22.1M

Revenue (TTM)

88.5M

Profit Margin

-39.85%

Return On Equity TTM

-383.09%

Biodesix Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biodesix Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Biodesix Inc image
Biodesix Inc
BUY$107.5M-97.03%NA-39.85%
IDEXX Laboratories Inc image
IDEXX Laboratories Inc
BUY$45.8B3.07%43.9924.62%
Agilent Technologies Inc image
Agilent Technologies Inc
BUY$32.7B-14.23%25.5218.26%
Thermo Fisher Scientific Inc image
Thermo Fisher Scientific Inc
BUY$173.9B-3.66%25.715.15%
Danaher Corporation image
Danaher Corporation
BUY$125.5B-30.1%34.3514.89%

Stock Returns calculator for Biodesix Inc Stock including INR - Dollar returns

The Biodesix Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Biodesix Inc investment value today

Current value as on today

₹96,739

Returns

-₹3,261

(-3.26%)

Returns from Biodesix Inc Stock

-₹12,838 (-12.84%)

Dollar Impact

₹9,577 (+9.58%)

Analyst Recommendation on Biodesix Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Biodesix Inc. Average target price of $30

Biodesix Inc Share Price Target

Get share price movements and forecasts by analysts on Biodesix Inc.

What analysts predicted

66.73%UPSIDE

Target Price

$30

Current Price

$9.98

Analyzed by

8 Analysts

Target

$30.00

Biodesix Inc target price $30, a slight upside of 66.73% compared to current price of $9.98. According to 8 analysts rating.

Biodesix Inc Stock’s Investor Sentiment and Interest

Search interest for Biodesix Inc Stock has decreased by -74% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-74% versus previous 30 day period

Biodesix Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
13
14
14
17
18
20
17
20
21
28
Gross Profit
10
11
11
14
13
16
14
15
17
23
Operating Income
-7
-6
-11
-8
-8
-6
-9
-9
-7
-1
EBITDA
-7
-5
-9
-7
-6
-5
-8
-8
-5
0
Interest Expense
2
2
2
1
2
1
1
1
2
2
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-10
-9
-13
-10
-10
-8
-11
-11
-8
-3
Income Tax Expense
2
-3
1
-
-1
-1
-
-
-
-
Net Income
-10
-9
-13
-10
-10
-8
-11
-11
-8
-3
Net Profit Margin
-81.16%
-62.31%
-91.87%
-60.30%
-56.51%
-40.39%
-61.82%
-57.29%
-40.04%
-13.84%

Biodesix Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
20
24
45
54
38
49
71
88
Gross Profit
16
18
23
23
24
36
55
66
Operating Income
-23
-26
-22
-40
-50
-41
-34
-27
EBITDA
-21
-24
-20
-35
-51
-37
-29
-21
Interest Expense
2
3
7
4
8
9
8
7
Depreciation
1
2
2
3
5
5
5
5
Income Before Tax
-26
-30
-31
-43
-65
-52
-42
-35
Income Tax Expense
0
0
5
1
14
5
-
-
Net Income
-26
-30
-31
-43
-65
-52
-42
-35
Net Profit Margin
-128.06%
-125.15%
-68.81%
-79.18%
-171.27%
-106.23%
-60.19%
-39.85%

Biodesix Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-9
-13
-10
-10
-8
-11
-11
-8
-3
Operating Cash Flow
-12
-15
-18
-10
-4
-8
-6
-8
0
Investing Cash Flow
-3
0
-1
0
0
0
0
0
0
Financing Cash Flow
21
0
51
0
0
0
9
4
1
Change in Cash
6
-14
30
-10
-5
-8
3
-4
2

Biodesix Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-30
-31
-43
-65
-52
-42
-35
Operating Cash Flow
-21
-21
-28
-44
-22
-48
-23
Investing Cash Flow
-1
-2
-2
-3
-23
-3
0
Financing Cash Flow
22
81
1
58
29
52
16
Change in Cash
0
56
-29
10
-16
0
-7

Global Institutional Holdings in Biodesix Inc

Funds
Holdings
Royal Bank of Canada
0.09%
HighTower Advisors, LLC
0.01%
Telemark Asset Management, LLC
3.24%
Geode Capital Management, LLC
0.41%
Birchview Capital, LP
0.2%
See all

Insights on Biodesix Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -11.46M → -3.98M (in $), with an average increase of 75.3% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 17.95M → 28.75M (in $), with an average increase of 14.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, IDEXX Laboratories, Inc. has given 16.8% return, outperforming this stock by 87.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, IDEXX Laboratories, Inc. has given 31.6% return, outperforming this stock by 37.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BDSX stock has moved down by -12.6%

About Biodesix Inc

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
OrganisationBiodesix Inc
Headquarters919 West Dillon Road, Louisville, CO, United States, 80027
IndustryDiagnostics & Research
CEOMr. Scott Hutton
E-voting on sharesClick here to vote

Key Management of Biodesix Inc

Name

Title

Dr. James R. Jett M.D.

Co-Chief Medical Officer

Dr. Michael N. Kammer Ph.D.

Head of Radiomics

Mr. Scott Hutton

President, CEO & Director

Ms. Robin Harper Cowie

CFO, Secretary & Treasurer

Mr. Kieran O'Kane

Chief Commercial Officer

Ms. Jessica Olbricht

Senior Director of Human Resources

Dr. Heinrich Roder D.Phil

Founder & CTO

Dr. Gary Anthony Pestano Ph.D.

Chief Scientific Officer

Ms. Bobbi Coffin

Chief Growth Officer

Dr. Steven C. Springmeyer FCCP, M.D.

Co-Chief Medical Officer

FAQs

What is Biodesix Inc share price today?

Biodesix Inc share price today is $9.98 as on at the close of the market. Biodesix Inc share today touched a day high of $10.37 and a low of $9.98.

What is the 52 week high and 52 week low for Biodesix Inc share?

Biodesix Inc share touched a 52 week high of $20.21 on and a 52 week low of $3.44 on . Biodesix Inc stock price today i.e. is closed at $9.98,which is 50.62% down from its 52 week high and 190.45% up from its 52 week low.

What is Biodesix Inc's market capitalisation today?

Biodesix Inc market capitalisation is $0.00T as on .

How to invest in Biodesix Inc Stock (BDSX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biodesix Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biodesix Inc Shares that will get you 0.1503 shares as per Biodesix Inc share price of $9.98 per share as on April 29, 2026 at 1:24 am IST.

What is the minimum amount required to buy Biodesix Inc Stock (BDSX) from India?

Indian investors can start investing in Biodesix Inc (BDSX) shares with as little as ₹94.52 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.20 in Biodesix Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Biodesix Inc share’s latest price of $9.98 as on April 29, 2026 at 1:24 am IST, you will get 1.0020 shares of Biodesix Inc. Learn more about fractional shares .

What are the returns that Biodesix Inc has given to Indian investors in the last 5 years?

Biodesix Inc stock has given -97.03% share price returns and 26.45% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?